MADRID, June 24, 2017 /PRNewswire/ --
The risk of blood clots in the veins of the legs or the lungs, known as venousthrombosis (VTE) is higher in cancer patients, and so is the risk of bleeding. Whereas anticoagulant therapy lowers the risk of thrombosis recurrence, it further increases the risk of bleeding. Previous studies suggested that the risks of dying from
(Logo: http://mma.prnewswire.com/media/524821/EHA_Logo.jpg )
Presenter: Dr Alejandro Lazo-Langner
Affiliation: Western University, Department of Medicine, London, Canada
Topic: ASSESSING THE RISK-BENEFIT OF ANTICOAGULANTS IN ELDERLY PATIENTS WITH CANCER-ASSOCIATED VENOUS THROMBOEMBOLISM: A POPULATION BASED STUDY
Abstract S441 will be presented by Alejandro Lazo-Langner on Saturday, June 24, 11:30 - 12:45 in Room N103.
About the EHA Annual Congress Hematology is a specialty that covers everything to do with blood: its origin in the bone marrow, diseases of blood and their treatments. The latest data on research and developments will be presented. The topics range from stem cell physiology and development, to leukemia, lymphoma, myeloma - diagnosis and treatment; red blood cells, white blood cells- and platelet disorders; thrombosis and bleeding disorders.
SOURCE European Hematology Association
Subscribe to our Free Newsletters!
Lazy eye or amblyopia occurs when sight in one eye is less than the other in early childhood due to ...
Tracheal or windpipe cancer is a rare cancer and its cause is unclear. The most common squamous ...
Tecovirimat can be used to treat smallpox disease in adult and pediatric patients who weigh at ...View All